RxPG News XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!  

Medical Research Health Special Topics World
 
  Home
 
 Careers 
 Dental
 Medical
 Nursing
 
 Latest Research 
 Aging
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Psychiatry
 Public Health
 Radiology
 Rheumatology
 Surgery
 Urology
 Alternative Medicine
 Medicine
 Epidemiology
 Sports Medicine
 Toxicology
 
 Medical News 
 Awards & Prizes
 Epidemics
 Health
 Healthcare
 Launch
 Opinion
 Professionals
 
 Special Topics 
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate
 
 DocIndia 
 Reservation Issue
 Overseas Indian Doctor

Last Updated: May 20, 2007 - 10:48:48 AM
News Report
Europe Channel

subscribe to Europe newsletter
Europe

   EMAIL   |   PRINT
Now a vaccine to control blood pressure
May 12, 2007 - 11:57:43 AM
High blood pressure which affects a third of all adults doubles the risk of dying from heart disease or stroke and is blamed for 60,000 deaths a year in Britain. It is currently treated with pills with side effects and some patients simply stop taking them.

Article options
 Email to a Friend
 Printer friendly version
 Europe channel RSS
 More Europe news
[RxPG] London, May 12 - British scientists have develop a vaccine which they claim will help people suffering from hypertension to control their blood pressure.

The vaccine developed by Cheshire-based drug firm Protherics has been successfully tested and is expected in the markets within five years.

The vaccine uses a protein found in limpets, a sea creature, to attack a hormone called angiotensin produced by the liver. Angiotensin raises blood pressure by narrowing arteries. The vaccine, however, turns the body's immune system against the hormone.

It would need a course of just three jabs, with a booster every six months.

A booster shot every six months, or even once a year, would keep blood pressure low, the researchers said.

People who have tried it have suffered a few side effects, although one in ten did complain of a brief flu-like illness.

Protherics is planning trials of an improved version of the vaccine, which is ten times more effective at stimulating the immune system than its original formula, the Daily Mail reported.

'Improving compliance in this way could save thousands from life-threatening complications such as heart attack or stroke,' said Andrew Heath, an official of Protherics.

High blood pressure which affects a third of all adults doubles the risk of dying from heart disease or stroke and is blamed for 60,000 deaths a year in Britain. It is currently treated with pills with side effects and some patients simply stop taking them.

The Swiss firm Cytos Biotechnology is also developing a similar vaccine that uses an empty virus shell to spur the immune system into action.





Related Europe News
Moore returns to Cannes with scathing look at healthcare
India section kicks off at Cannes
Nesta extends contract with AC Milan until 2011
Federer, Nadal roll on into Hamburg semis
Fingerprint could identify smoker, drinker
Devil or wily lawyer - Cannes film looks at Jacques Verges
French president unveils new cabinet
'Blair could be in run for World Bank top job'
India's growing economic clout high on Brown's agenda
Roma snatch Italian Cup from Inter

Subscribe to Europe Newsletter
E-mail Address:

 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
© All rights reserved 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us